Office-based treatment of opiate addiction with a sublingual-tablet formulation of buprenorphine and naloxone | HCV Guidance

HCV Guidance: Recommendations for Testing, Managing, and Treating Hepatitis C

Office-based treatment of opiate addiction with a sublingual-tablet formulation of buprenorphine and naloxone

Fudala PJ, Bridge TP, Herbert S, et al. Office-based treatment of opiate addiction with a sublingual-tablet formulation of buprenorphine and naloxone. N Engl J Med. 2003;349(10):949-958.

Publication Type:

Journal Article

Authors:

Fudala, PJ; Bridge, TP; Herbert, S; et, al

Source:

N Engl J Med, Volume 349, Issue 10, p.949-958 (2003)

Cited On:

Key Populations: Identification and Management of HCV in People Who Inject Drugs

Export Citation:

RIS Format

Top